The Essential Guide To Biophotonics Market, optimal business decisions and strengthen their COVID-19 preparedness
The global Biophotonics Market is categorized based on product type, application, end-use industry, region, and competitive backdrop. Under this section, the most fundamental segments of the Biophotonics Market have been emphasized to help the targeted readers and the companies involved in this sector make optimal business decisions and strengthen their COVID-19 preparedness
Key players of the industry include Affymetrix, Inc., Zecotek Photonics Inc., Andor Technology Ltd, FEI Company, Carl Zeiss AG, Hamamatsu Photonics K.K. Lumenis Ltd., and Becton, Dickinson, and Company, among others.
Read More: https://www.emergenresearch.com/industry-report/biophotonics-market
The Global Biophotonics Market is anticipated to garner a valuation of USD 118.19 Billion by 2027, growing at a CAGR of 11.7%,
As per the latest analysis by Emergen Research. The rapid advancements in optical technologies, extensive research, and the augmenting requirement for early diagnosis are potential market drivers anticipated to bolster the industry’s growth during the projected timespan. Biophotonics finds numerous applications due to the remarkable ability to harness light-weight to understand the complexity of functioning cells and tissues in organisms, thereby conferring an advanced level of diagnosis.
Owing to its extensive application, the key market players are actively capitalizing on the technique to gain a robust footing in the industry. However, the market is growing at a slow pace due to the low acceptance rate, sensitivity issues, and concerns regarding reliability and quality.
The market is forecast to grow at a substantial rate owing to the rising adoption of technology across numerous industrial verticals such as biotechnology, medicine, agriculture, and other R&D areas of science.
North America is forecast to grow at a CAGR of 11.2% during the predicted span due to the growing investment in the R&D sector and the increasing cancer occurrences in the region. The augmented healthcare infrastructure development and expenditure coupled with growing initiatives from the government are anticipated to accelerate the market’s growth in the area.
Technology Outlook (Revenue, USD Billion; 2017-2027)
- In-vitro
- In-vivo
Application Outlook (Revenue, USD Billion; 2017-2027)
- Light Therapy
- Microscopy
- Endoscopy
- Surface Imaging
- Spectromolecular
- Biosensors
End-User Outlook (Revenue, USD Billion; 2017-2027)
- Medical Therapeutics
- Medical Diagnostics
- Test Components
